Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Gross Margin (2016 - 2020)

Historic Gross Margin for Avadel Pharmaceuticals (AVDL) over the last 12 years, with Q2 2020 value amounting to 67.45%.

  • Avadel Pharmaceuticals' Gross Margin fell 119200.0% to 67.45% in Q2 2020 from the same period last year, while for Mar 2021 it was 67.45%, marking a year-over-year decrease of 119900.0%. This contributed to the annual value of 74.29% for FY2020, which is 52300.0% down from last year.
  • As of Q2 2020, Avadel Pharmaceuticals' Gross Margin stood at 67.45%, which was down 119200.0% from 79.93% recorded in Q1 2020.
  • Avadel Pharmaceuticals' Gross Margin's 5-year high stood at 93.99% during Q4 2016, with a 5-year trough of 67.45% in Q2 2020.
  • For the 5-year period, Avadel Pharmaceuticals' Gross Margin averaged around 84.61%, with its median value being 86.12% (2018).
  • As far as peak fluctuations go, Avadel Pharmaceuticals' Gross Margin skyrocketed by 18042100bps in 2016, and later tumbled by -123700bps in 2018.
  • Avadel Pharmaceuticals' Gross Margin (Quarter) stood at 93.99% in 2016, then fell by -6bps to 88.35% in 2017, then fell by -10bps to 79.48% in 2018, then decreased by -2bps to 78.04% in 2019, then dropped by -14bps to 67.45% in 2020.
  • Its last three reported values are 67.45% in Q2 2020, 79.93% for Q1 2020, and 78.04% during Q4 2019.